Acute Myeloid Leukaemia (AML) Clinical Trials in Philadelphia, Pennsylvania

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML